Fast and sensitive LC–MS/MS method for the simultaneous determination of Lisinopril (cas 76547-98-3) and hydrochlorothiazide in human plasma
-
Add time:07/18/2019 Source:sciencedirect.com
A sensitive and rapid liquid chromatography-tandem mass spectrometry (LC–MS/MS) method has been developed for the simultaneous determination of Lisinopril (cas 76547-98-3) (LIS) and hydrochlorothiazide (HCTZ) in human plasma using their labeled internal standards (ISs). Sample pre-treatment involved solid phase extraction on Waters Oasis HLB cartridges using 100 µL of plasma, followed by liquid chromatography on Hypersil Gold C18 (50 mm×3.0 mm, 5 µm) column. The analytes were eluted within 2.0 min using acetonitrile-5.0 mM ammonium formate, pH 4.5 (85:15, v/v) as the mobile phase. The analytes and ISs were analyzed in the negative ionization mode and quantified using multiple reaction monitoring. The method showed excellent linearity over the concentration range of 0.50–250.0 ng/mL for both the analytes. The intra-batch and inter-batch precision (% CV) was ≤5.26% and their extraction recoveries were in the range of 96.6%–103.1%. Matrix effect evaluated in terms of IS-normalized matrix factors ranged from 0.97 to 1.03 for both the analytes. The validated method was successfully applied to determine the plasma concentration of the drugs using 10 mg lisinopril and 12.5 mg hydrochlorothiazide fixed dose formulation in 18 healthy Indian volunteers.
We also recommend Trading Suppliers and Manufacturers of Lisinopril (cas 76547-98-3). Pls Click Website Link as below: cas 76547-98-3 suppliers
Prev:Development and characterization of sublingual tablet of Lisinopril (cas 76547-98-3)
Next:The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of Lisinopril (cas 76547-98-3) vs. perindopril: A cohort study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of Lisinopril (cas 76547-98-3) vs. perindopril: A cohort study07/19/2019
- Development and characterization of sublingual tablet of Lisinopril (cas 76547-98-3)07/17/2019
- Daily Lisinopril (cas 76547-98-3) vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial07/16/2019
- The cough reflex is upregulated by Lisinopril (cas 76547-98-3) microinjected into the caudal nucleus tractus solitarii of the rabbit07/15/2019
- An innovative validated spectrofluorimetric method for determination of Lisinopril (cas 76547-98-3) in presence of hydrochlorothiazide; application to content uniformity testing07/14/2019
- Effect of amlodipine, Lisinopril (cas 76547-98-3) and allopurinol on acetaminophen-induced hepatotoxicity in rats07/13/2019
- Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis07/12/2019
- Randomized Trial of Lisinopril (cas 76547-98-3) Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer07/11/2019